ProPhase Labs (PRPH) Misses Q3 EPS by 13c

ProPhase Labs (NASDAQ: PRPH) reported Q3 EPS of $0.06, $0.13 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $24.2 million versus the consensus estimate of $18.42 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.

You May Also Be Interested In

• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
• Air Products cancels Louisiana clean energy project, faces $2.9B charge
• Quarterhill to buy Conduent tolling unit for cash and stock